The situation is further complicated with the two most prevalent age-related neurodegenerative diseases, AD and Parkinson’s disease (PD), for both of which there is growing evidence of altered structure and function of the BBB, including downregulation of TJ proteins and efflux transporters such as P-gp (Bors et al., 2018). This evidence concerns the gene PGP and Parkinson disease.